Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-05-04 Sale | 2026-05-05 8:34 pm | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 4,750 | $227.95 | $1,082,771 | 230,141 (Direct) | View |
| 2026-04-22 Sale | 2026-04-23 9:01 pm | Axsome Therapeutics Inc. | AXSM | Maizel Ari Chief Commercial Officer | 7,500 | $182.42 | $1,368,150 | 23,710 (Direct) | View |
| 2026-02-26 Sale | 2026-02-27 7:00 pm | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 25,000 | $161.11 | $4,027,750 | 450,996 (Indirect Direct) | View |
| 2026-02-26 Sale | 2026-02-27 7:00 pm | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 35,378 | $161.88 | $5,726,991 | 0 (Direct) | View |
| 2026-02-02 Sale | 2026-02-02 6:30 pm | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 32,410 | $185.6 | $6,015,296 | 7,351,729 (Indirect Direct) | View |
| 2026-01-22 Sale | 2026-01-23 7:00 pm | Axsome Therapeutics Inc. | AXSM | Pizzie Nick Chief Financial Officer | 12,000 | $187.92 | $2,255,040 | 148,076 (Indirect Direct) | View |
| 2026-01-21 Sale | 2026-01-23 7:00 pm | Axsome Therapeutics Inc. | AXSM | Maizel Ari Chief Commercial Officer | 7,500 | $184.44 | $1,383,300 | 31,210 (Direct) | View |
| 2026-01-05 Sale | 2026-01-07 7:00 pm | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 139,414 | $171.3 | $23,881,618 | 7,540,931 (Indirect Direct) | View |
| 2025-12-31 Sale | 2026-01-02 7:02 pm | Axsome Therapeutics Inc. | AXSM | Saad Mark E Director | 37,577 | $165.18 | $6,206,969 | 10,302 (Indirect Direct) | View |
| 2025-12-02 Sale | 2025-12-04 7:39 pm | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 79,973 | $145.66 | $11,648,582 | 7,908,480 (Indirect Direct) | View |
| 2025-11-03 Sale | 2025-11-05 7:01 pm | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 163,939 | $133.07 | $21,815,669 | 8,201,129 (Indirect Direct) | View |
| 2025-10-06 Sale | 2025-10-08 9:08 pm | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 45,384 | $119.38 | $5,418,060 | 8,637,875 (Indirect Direct) | View |
| 2025-09-22 Sale | 2025-09-22 7:00 pm | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 10,000 | $115.96 | $1,159,600 | 35,378 (Direct) | View |
| 2025-09-16 Sale | 2025-09-17 7:00 pm | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 45,783 | $114.48 | $5,241,127 | 0 (Direct) | View |
| 2025-09-12 Sale | 2025-09-16 7:36 pm | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 62,880 | $117.08 | $7,361,891 | 8,789,781 (Indirect Direct) | View |
| 2025-09-08 Purchase | 2025-09-09 8:11 pm | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 1,575 | $127.28 | $200,466 | 452,068 (Indirect Direct) | View |
| 2025-09-05 Sale | 2025-09-05 7:43 pm | Axsome Therapeutics Inc. | AXSM | Saad Mark E Director | 9,127 | $125.07 | $1,141,514 | 10,302 (Indirect Direct) | View |
| 2025-09-02 Sale | 2025-09-02 7:11 pm | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 13,464 | $123.68 | $1,665,228 | 57,510 (Direct) | View |
| 2025-08-27 Sale | 2025-08-29 7:08 pm | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 60,000 | $121.72 | $7,303,400 | 70,974 (Direct) | View |
| 2025-08-22 Sale | 2025-08-26 7:00 pm | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 36,694 | $120.05 | $4,405,216 | 130,974 (Direct) | View |
| 2025-06-20 Sale | 2025-06-23 7:42 pm | Axsome Therapeutics Inc. | AXSM | Murdock Hunter R. General Counsel | 13,514 | $101.42 | $1,370,647 | 38,752 (Direct) | View |
| 2025-06-16 Sale | 2025-06-18 9:16 pm | Axsome Therapeutics Inc. | AXSM | Murdock Hunter R. General Counsel | 22,500 | $101.19 | $2,276,850 | 112,149 (Direct) | View |
| 2025-06-09 Sale | 2025-06-10 7:00 pm | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 25,000 | $110.44 | $2,761,000 | 5,783 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-05-04 Exercise | 2026-05-05 8:34 pm | 2020-03-19 2029-03-19 | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 4,750 | $0 | 230,141 (Direct) | View |
| 2026-05-04 Exercise | 2026-05-05 8:34 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 4,750 | $12.95 | 230,141 (Direct) | View |
| 2026-04-21 Option Award | 2026-04-23 9:02 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 8,669 | $0 | 8,669 (Direct) | View |
| 2026-04-21 Option Award | 2026-04-23 9:02 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 24,081 | $0 | 24,081 (Direct) | View |
| 2026-04-22 Exercise | 2026-04-23 9:01 pm | 2024-09-25 2033-09-25 | Axsome Therapeutics Inc. | AXSM | Maizel Ari Chief Commercial Officer | 7,500 | $0 | 23,710 (Direct) | View |
| 2026-04-22 Exercise | 2026-04-23 9:01 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Maizel Ari Chief Commercial Officer | 7,500 | $70.73 | 23,710 (Direct) | View |
| 2026-04-21 Option Award | 2026-04-23 9:01 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Maizel Ari Chief Commercial Officer | 7,224 | $0 | 7,224 (Direct) | View |
| 2026-04-21 Option Award | 2026-04-23 9:00 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Pizzie Nick Chief Financial Officer | 8,188 | $0 | 8,188 (Direct) | View |
| 2026-04-21 Option Award | 2026-04-23 9:00 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Murdock Hunter R. General Counsel | 7,224 | $0 | 7,224 (Direct) | View |
| 2026-02-26 Option Award | 2026-02-27 7:10 pm | N/A 2036-02-26 | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 54,623 | $0 | 54,623 (Direct) | View |
| 2026-02-26 Option Award | 2026-02-27 7:10 pm | N/A 2036-02-26 | Axsome Therapeutics Inc. | AXSM | Pizzie Nick Chief Financial Officer | 18,570 | $0 | 18,570 (Direct) | View |
| 2026-02-26 Option Award | 2026-02-27 7:10 pm | N/A 2036-02-26 | Axsome Therapeutics Inc. | AXSM | Murdock Hunter R. General Counsel | 16,385 | $0 | 16,385 (Direct) | View |
| 2026-02-26 Option Award | 2026-02-27 7:10 pm | N/A 2036-02-26 | Axsome Therapeutics Inc. | AXSM | Maizel Ari Chief Commercial Officer | 16,385 | $0 | 16,385 (Direct) | View |
| 2026-02-26 Option Award | 2026-02-27 7:10 pm | N/A 2036-02-26 | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 19,663 | $0 | 19,663 (Direct) | View |
| 2026-02-26 Exercise | 2026-02-27 7:00 pm | 2019-03-12 2028-03-12 | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 35,378 | $0 | 0 (Direct) | View |
| 2026-02-26 Exercise | 2026-02-27 7:00 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 35,378 | $2.85 | 0 (Direct) | View |
| 2026-02-23 Exercise | 2026-02-25 7:00 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 6,250 | $4.95 | 483,717 (Direct) | View |
| 2026-02-23 Exercise | 2026-02-25 7:00 pm | 2018-03-15 2027-03-15 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 6,250 | $0 | 483,717 (Direct) | View |
| 2026-02-20 Exercise | 2026-02-23 7:23 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 12,485 | $4.95 | 483,717 (Direct) | View |
| 2026-02-20 Exercise | 2026-02-23 7:23 pm | 2018-03-15 2027-03-15 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 12,485 | $0 | 483,717 (Direct) | View |
| 2026-02-10 Exercise | 2026-02-10 7:11 pm | 2017-05-27 2026-05-27 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 5,193 | $0 | 457,261 (Direct) | View |
| 2026-02-10 Exercise | 2026-02-10 7:11 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 5,193 | $8.02 | 457,261 (Direct) | View |
| 2026-02-02 Exercise | 2026-02-02 6:30 pm | 2017-05-27 2026-05-27 | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 32,410 | $0 | 7,351,729 (Direct) | View |
| 2026-02-02 Exercise | 2026-02-02 6:30 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 32,410 | $8.02 | 7,351,729 (Direct) | View |
| 2026-01-22 Exercise | 2026-01-23 7:00 pm | 2019-05-16 2028-05-16 | Axsome Therapeutics Inc. | AXSM | Pizzie Nick Chief Financial Officer | 12,000 | $0 | 148,076 (Direct) | View |
| 2026-01-22 Exercise | 2026-01-23 7:00 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Pizzie Nick Chief Financial Officer | 12,000 | $3.5 | 148,076 (Direct) | View |
| 2026-01-21 Exercise | 2026-01-23 7:00 pm | 2024-09-25 2033-09-25 | Axsome Therapeutics Inc. | AXSM | Maizel Ari Chief Commercial Officer | 7,500 | $0 | 31,210 (Direct) | View |
| 2026-01-21 Exercise | 2026-01-23 7:00 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Maizel Ari Chief Commercial Officer | 7,500 | $70.73 | 31,210 (Direct) | View |
| 2026-01-05 Exercise | 2026-01-07 7:00 pm | 2017-05-27 2026-05-27 | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 139,414 | $0 | 7,540,931 (Direct) | View |
| 2026-01-05 Exercise | 2026-01-07 7:00 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 139,414 | $8.02 | 7,540,931 (Direct) | View |
| 2025-12-31 Exercise | 2026-01-02 7:02 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Saad Mark E Director | 31,346 | $4.95 | 10,302 (Direct) | View |
| 2025-12-31 Exercise | 2026-01-02 7:02 pm | 2017-05-27 2026-05-27 | Axsome Therapeutics Inc. | AXSM | Saad Mark E Director | 37,577 | $0 | 10,302 (Direct) | View |
| 2025-12-31 Exercise | 2026-01-02 7:02 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Saad Mark E Director | 6,231 | $8.02 | 10,302 (Direct) | View |
| 2025-12-02 Exercise | 2025-12-04 7:39 pm | 2017-05-27 2026-05-27 | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 79,973 | $0 | 7,908,480 (Direct) | View |
| 2025-12-02 Exercise | 2025-12-04 7:39 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 79,973 | $8.02 | 7,908,480 (Direct) | View |
| 2025-11-03 Exercise | 2025-11-05 7:01 pm | 2017-05-27 2026-05-27 | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 163,939 | $0 | 8,201,129 (Direct) | View |
| 2025-11-03 Exercise | 2025-11-05 7:01 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 163,939 | $8.02 | 8,201,129 (Direct) | View |
| 2025-10-06 Exercise | 2025-10-08 9:08 pm | 2017-05-27 2026-05-27 | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 45,384 | $0 | 8,637,875 (Direct) | View |
| 2025-10-06 Exercise | 2025-10-08 9:08 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 45,384 | $8.02 | 8,637,875 (Direct) | View |
| 2025-09-22 Exercise | 2025-09-22 7:00 pm | 2019-03-12 2028-03-12 | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 10,000 | $0 | 35,378 (Direct) | View |
| 2025-09-22 Exercise | 2025-09-22 7:00 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 10,000 | $2.85 | 35,378 (Direct) | View |
| 2025-09-16 Exercise | 2025-09-17 7:00 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 25,000 | $4.95 | 0 (Direct) | View |
| 2025-09-16 Exercise | 2025-09-17 7:00 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 15,000 | $4.85 | 0 (Direct) | View |
| 2025-09-16 Exercise | 2025-09-17 7:00 pm | 2018-03-15 2027-03-15 | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 40,000 | $0 | 0 (Direct) | View |
| 2025-09-12 Exercise | 2025-09-16 7:36 pm | 2017-05-27 2026-05-27 | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 62,880 | $0 | 8,789,781 (Direct) | View |
| 2025-09-12 Exercise | 2025-09-16 7:36 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 62,880 | $8.02 | 8,789,781 (Direct) | View |
| 2025-09-05 Exercise | 2025-09-05 7:43 pm | 2016-11-19 2025-11-19 | Axsome Therapeutics Inc. | AXSM | Saad Mark E Director | 9,127 | $0 | 10,302 (Direct) | View |
| 2025-09-05 Exercise | 2025-09-05 7:43 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Saad Mark E Director | 9,127 | $9 | 10,302 (Direct) | View |
| 2025-06-20 Exercise | 2025-06-23 7:42 pm | 2023-03-04 2032-03-04 | Axsome Therapeutics Inc. | AXSM | Murdock Hunter R. General Counsel | 13,514 | $0 | 38,752 (Direct) | View |
| 2025-06-20 Exercise | 2025-06-23 7:42 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Murdock Hunter R. General Counsel | 13,514 | $29.91 | 38,752 (Direct) | View |
| 2025-06-16 Exercise | 2025-06-18 9:16 pm | 2023-03-04 2032-03-04 | Axsome Therapeutics Inc. | AXSM | Murdock Hunter R. General Counsel | 22,500 | $0 | 112,149 (Direct) | View |
| 2025-06-16 Exercise | 2025-06-18 9:16 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Murdock Hunter R. General Counsel | 22,500 | $29.91 | 112,149 (Direct) | View |
| 2025-06-06 Option Award | 2025-06-10 7:00 pm | N/A 2035-06-06 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 4,595 | $0 | 4,595 (Direct) | View |
| 2025-06-06 Option Award | 2025-06-10 7:00 pm | N/A 2035-06-06 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 4,595 | $0 | 4,595 (Direct) | View |
| 2025-06-06 Option Award | 2025-06-10 7:00 pm | N/A 2035-06-06 | Axsome Therapeutics Inc. | AXSM | Saad Mark E Director | 4,595 | $0 | 4,595 (Direct) | View |
| 2025-06-09 Exercise | 2025-06-10 7:00 pm | 2017-05-27 2026-05-27 | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 25,000 | $0 | 5,783 (Direct) | View |
| 2025-06-09 Exercise | 2025-06-10 7:00 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 25,000 | $8.02 | 5,783 (Direct) | View |
| 2025-06-06 Option Award | 2025-06-10 7:00 pm | N/A 2035-06-06 | Axsome Therapeutics Inc. | AXSM | Mahony Susan Director | 4,595 | $0 | 4,595 (Direct) | View |